CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Sensory Integration Therapy and Auditory Integration Therapy

This policy governs coverage determinations for sensory integration therapy (SIT) and auditory integration therapy (AIT) for Blue Cross Blue Shield - Rhode Island members, distinguishing positions for BlueCHiP for Medicare and Commercial products.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicySensory Integration Therapy and Auditory Integration Therapy

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateMar 1, 2019

Next Review Date

Key ActionVerify member benefits and eligibility with the provider call center before delivering services.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

1CPT code explicitly mentioned

Medically necessaryMedicare coverage

Not medically necessaryCommercial coverage

MultipleProvider updates

Coverage Criteria

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

inv-01: BlueCHiP for Medicare - Medically Necessary

Covered when ALL of the following are met:

Medicare: Acquired sensory problems: Sensory integration therapy and auditory integration therapy are considered medically necessary when used to treat sensory problems resulting from head trauma, illness, or acute neurologic events (including cerebrovascular accidents).

Therapy is not appropriate for patients with progressive neurological conditions without potential for functional adaptation; utilization should be infrequent.

inv-02: Commercial Products - Not Medically Necessary

Not covered when ANY of the following apply:

Commercial: Developmental disorders: Sensory integration therapy and auditory integration therapy for children and adults with autism spectrum disorder, intellectual disability (mental retardation), or learning disabilities is considered not medically necessary because evidence is insufficient to determine effects on health outcomes.

The largest body of evidence for auditory integration therapy is in autism; systematic reviews failed to show meaningful clinical improvements.

Sensory integration treatments are not appropriate for patients with progressive neurological conditions without potential for functional adaptation. The policy specifies that SIT/AIT are intended to facilitate changes in sensory processing after an acquired insult (for example, head trauma, illness, or acute neurologic events such as cerebrovascular accidents) and are not considered curative for progressive disorders; therefore these therapies should not be used when meaningful functional adaptation is unlikely.

For Commercial Products, sensory integration therapy (SIT) and auditory integration therapy (AIT) for children and adults with autism spectrum disorder, intellectual disability (mental retardation), or learning disabilities are considered not medically necessary. The policy cites insufficient evidence of meaningful clinical benefit—particularly noting that the largest body of evidence for AIT is in autism and systematic reviews have failed to demonstrate clinical improvements—so these services would be denied for these indications.

Provider Actions & Billing

Prior Authorization

Prior authorization: Not applicable — verify benefits

Prior authorization is not applicable under this policy. Providers should still refer to the member's Benefit Booklet / Evidence of Coverage or Subscriber Agreement because benefits may vary by group and contract.

Step Therapy

Step therapy: None specified

No step therapy requirements are specified in this policy. Coverage and any utilization management requirements may vary by contract.

Documentation Required

Benefit verification and documentation

Verify member-specific benefits and eligibility with the provider call center and confirm applicable coverage in the member's Evidence of Coverage / Subscriber Agreement or employer agreement before providing services.

Benefits and eligibility are determined by the member's subscriber agreement, member certificate, or employer agreement.
Contact the provider call center for member-specific benefit information.

Denial Risk

Denial risk for Commercial products (SIT/AIT in developmental disorders)

For Commercial Products, sensory integration therapy (SIT) and auditory integration therapy (AIT) for children and adults with autism, intellectual disability (mental retardation), or learning disabilities is considered not medically necessary and would be denied.

Denial likelihood: claims for SIT/AIT in the specified developmental disorders will be denied as not supported by evidence.

Background

Sensory integration therapy (SIT) aims to improve how the brain processes and adapts to sensory information rather than teaching discrete skills. Typical SIT approaches use individualized, one-on-one activities that provide vestibular, proprioceptive, and tactile input tailored to a patient’s specific sensory processing deficits to promote more adaptive responses.

Auditory integration therapy (AIT) is a related approach that uses graded exposure to modified sounds or filtered music (for example, methods such as the Berard protocol or Tomatis techniques). A commonly described Berard schedule involves two half‑hour sessions separated by at least three hours over ten consecutive days during which patients listen to recordings with selected frequencies attenuated.

The policy indicates SIT/AIT are most often associated with pediatric populations but may be considered medically necessary in non‑pediatric patients when treating acquired sensory problems resulting from head trauma, illness, or acute neurologic events (including cerebrovascular accidents). The policy also notes these therapies are not appropriate for progressive neurological conditions without potential for functional adaptation and that utilization should be infrequent.

Definitions

Sensory integration therapy (SIT)

DefinitionSensory integration therapy (SIT): therapy intended to improve how the brain processes and adapts to sensory information rather than teaching specific skills; typically delivered one-on-one by occupational therapists with specialized training.

Typical activitiesVestibular input: swings and similar equipment commonly used to provide balance/motion stimuli.

Typical activitiesProprioceptive input: activities using trapeze bars, large foam pillows, or mats to stimulate somatosensory pathways for body-position awareness.

Typical activitiesTactile input: activities and surface textures providing light touch or deep pressure to address tactile reception deficits.

Delivery and durationUsually one-on-one sessions as part of occupational therapy or cognitive rehabilitation; programs may continue for more than one year depending on needs.

Auditory integration therapy (AIT)

DefinitionAuditory integration therapy (AIT): a method using gradual exposure to modified sounds (filtered or frequency-altered music) intended to reduce hypersensitivity to certain frequencies.

Common method (Berard)Berard method: typically involves two half-hour sessions separated by at least 3 hours each day for 10 consecutive days, during which patients listen to modified recordings.

Other methodsTomatis method: listening to electronically-modified music and speech; Samonas Sound: listening to filtered music, voices, and nature sounds.

Target populations and evidenceProposed for learning disabilities, autism spectrum disorder, pervasive developmental disorder, and ADHD; largest evidence base is in autism but systematic reviews failed to demonstrate meaningful clinical improvements.

Revision History

2019-12Provider UpdateLatest

Provider Update published in December 2019 reflecting policy communications to providers.

2019-02Provider Update

Provider Update published in February 2019 regarding coverage communications.

2017-06Provider Update

Provider Update published in June 2017 regarding policy notifications to providers.

2016-10Provider Update

Provider Update published in October 2016 communicating policy information to providers.

2015-04Provider Update

Provider Update published in April 2015 as an earlier provider communication.